News
Q1 2025 Management View CEO Linda Marban reviewed progress on the Biologics License Application (BLA) for deramiocel, targeting full approval for treating Duchenne muscular dystrophy (DMD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback